Immunopathology and molecular diagnosis of autoimmune bullous diseases

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 3, 2007, Pages 462-481

  Mihai, Sidonia ^a   Sitaru, Cassian ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Autoimmunity; ELISA; Immunoblotting; Immunofluorescence

Indexed keywords

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; DERMATITIS HERPETIFORMIS; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; IMMUNOLOGY; PATHOLOGY; PEMPHIGUS;

ANIMALS; AUTOIMMUNE DISEASES; DERMATITIS HERPETIFORMIS; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMANS; PEMPHIGOID, BULLOUS; PEMPHIGUS; SKIN DISEASES, VESICULOBULLOUS;

EID: 34547348003     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00033.x     Document Type: Article

References (160)

1. Rose C, Brocker EB, Zillikens D. Stellenwert der histologischen Untersuchung in der Diagnostik bulloser Autoimmundermatosen. J Dtsch Dermatol Ges. 2004 2 : 96 104.
2. Sitaru C, Goebeler M, Zillikens D. Bullöse Autoimmundermatosen (I): Pathogenese und Diagnostik. JDDG. 2004 2 : 123 39.
3. Lever WF. Pemphigus. Medicine. 1953 32 : 1 123.
4. Sitaru C. Blasen bildende Autoimmundermatosen. In : Schöfer, H and Baur-Beger, S, editors. Wiesbaden : Derma-Net-Online 2007. 1 ed. BBS-Verlag 2007.
5. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med. 2006 355 : 1800 10.
6. Hashimoto T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res. 2003 295 : S2 11.
7. Payne AS, Hanakawa Y, Amagai M, Stanley JR. Desmosomes and disease: pemphigus and bullous impetigo. Curr Opin Cell Biol. 2004 16 : 536 43.
8. Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp Dermatol. 2005 14 : 861 75.
9. Kottke MD, Delva E, Kowalczyk AP. The desmosome: cell science lessons from human diseases. J Cell Sci. 2006 119 : 797 806.
10. Eyre RW, Stanley JR. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. J Exp Med. 1987 165 : 1719 24.
11. Eyre RW, Stanley JR. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest. 1988 81 : 807 12.
12. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991 67 : 869 77.
13. Kljuic A, Bazzi H, Sundberg JP, Martinez-Mir A, O'Shaughnessy R, Mahoney MG, Levy M, Montagutelli X, Ahmad W, Aita VM, Gordon D, Uitto J, Whiting D, Ott J, Fischer S, Gilliam TC, Jahoda CA, Morris RJ, Panteleyev AA, Nguyen VT, Christiano AM. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell. 2003 113 : 249 60.
14. Nguyen VT, Ndoye A, Grando SA. Pemphigus vulgaris antibody identifies pemphaxin. A novel ker-atinocyte annexin-like molecule binding acetylcholine. J Biol Chem. 2000 275 : 29466 76.
15. Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol. 2000 157 : 1377 91.
16. Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N, Nishikawa T. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol. 1997 159 : 2010 7.
17. Hahn K, Kippes W, Amagai M, Rzany B, Bröcker EB, Zillikens D. Klinik und Immunpathologie bei 48 Patienten mit Pemphigus. Hautarzt. 2000 51 : 670 7.
18. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982 306 : 1189 96.
19. Roscoe JT, Diaz L, Sampaio SA, Castro RM, Labib RS, Takahashi Y, Patel H, Anhalt GJ. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol. 1985 85 : 538 41.
20. Rock B, Martins CR, Theofilopoulos AN, Balderas RS, Anhalt GJ, Labib RS, Futamura S, Rivitti EA, Diaz LA. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med. 1989 320 : 1463 9.
21. Beutner EH, Lever WF, Witebsky E. Autoantibodies in pemphigus vulgaris. Response to an intercellular substance of epidermis. JAMA. 1965 92 : 682 8.
22. Beutner EH, Jordon RE. Demonstration of skin antibodies in serum of pemphigus vulgaris patients by indirect immunofluorescence staining. Proc Soc Exp Biol Med. 1964 117 : 505 10.
23. Stanley JR, Yaar M, Hawley-Nelson P, Katz SI. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest. 1982 70 : 281 8.
24. Hashimoto T, Amagai M, Garrod DR, Nishikawa T. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1. Epithelial Cell Biol. 1995 4 : 63 9.
25. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol. 1999 40 : 167 70.
26. Stanley JR, Koulu L, Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest. 1984 74 : 313 20.
27. Koulu L, Kusumi A, Steinberg MS, Klaus-Kovtun V, Stanley JR. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med. 1984 160 : 1509 18.
28. Stanley JR, Koulu L, Klaus-Kovtun V, Steinberg MS. A monoclonal antibody to the desmosomal glyco-protein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol. 1986 136 : 1227 30.
29. Jablonska S, Chorzelski TP, Beutner EH, Chorzelska J. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol. 1975 14 : 353 9.
30. Ishii K, Amagai M, Komai A, Ebihara T, Chorzelski TP, Jablonska S, Ohya K, Nishikawa T, Hashimoto T. Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol. 1999 135 : 943 7.
31. Senear FE, Usher B. An unusual type of pemphigus combining features of lupus erythematosus. Arch Dermatol. 1926 13 : 761 81.
32. Korman NJ, Eyre RW, Zone J, Stanley JR. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol. 1991 96 : 273 6.
33. Schmidt E, Bröcker EB, Zillikens D. Pemphigus: Verlust des desmosomalen Zell-Zell-Kontaktes. Hautarzt 2000 51 : 309 18.
34. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H, Mutasim D, Ariss-Abdo L. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990 323 : 1729 35.
35. Hashimoto T. Immunopathology of paraneoplastic pemphigus. Clin Dermatol. 2001 19 : 675 82.
36. Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando SA. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001 137 : 193 206.
37. Billet SE, Grando SA, Pittelkow MR. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity. 2006 39 : 617 30.
38. Wang J, Zhu X, Li R, Tu P, Wang R, Zhang L, Li T, Chen X, Wang A, Yang S, Wu Y, Yang H, Ji S. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol. 2005 141 : 1285 93.
39. Wang J, Bu DF, Li T, Zheng R, Zhang BX, Chen XX, Zhu XJ. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol. 2005 153 : 558 64.
40. Hashimoto T, Amagai M, Watanabe K, Chorzelski TP, Bhogal BS, Black MM, Stevens HP, Boorsma DM, Korman NJ, Gamou S, Shimizu N, Nishikawa T. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol. 1995 104 : 829 34
41. Nagata Y, Karashima T, Watt FM, Salmhofer W, Kanzaki T, Hashimoto T. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin. J Invest Dermatol. 2001 116 : 556 63.
42. Zhang B, Zheng R, Wang J, Bu D, Zhu X. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients. J Invest Dermatol. 2006 126 : 832 40.
43. Huilgol SC, Black MM. Management of the immunobullous disorders. II. Pemphigus [see comments]. Clin Exp Dermatol. 1995 20 : 283 93.
44. Hashimoto T. Immunopathology of IgA pemphigus. Clin Dermatol. 2001 19 : 683 9.
45. Hashimoto T, Kiyokawa C, Mori O, Miyasato M, Chidgey MA, Garrod DR, Kobayashi Y, Komori K, Ishii K, Amagai M, Nishikawa T. Human desmocollin 1(Dsc1) is an autoantigen for the sub-corneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol. 1997 109 : 127 31
46. Wang J, Kwon J, Ding X, Fairley JA, Woodley DT, Chan LS. Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis. Am J Pathol. 1997 150 : 1901 7.
47. Karpati S, Amagai M, Liu WL, Dmochowski M, Hashimoto T, Horvath A. Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus. Exp Dermatol. 2000 9 : 224 8.
48. Hashimoto T, Komai A, Futei Y, Nishikawa T, Amagai M. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus. Arch Dermatol. 2001 137 : 735 8.
49. Ishii N, Ishida-Yamamoto A, Hashimoto T. Immunolocalization of target autoantigens in IgA pemphigus. Clin Exp Dermatol. 2004 29 : 62 6.
50. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell. 1981 24 : 897 903.
51. Stanley JR, Woodley DT, Katz SI. Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol. 1984 82 : 108 11.
52. Mueller S, Klaus-Kovtun V, Stanley JR. A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol. 1989 92 : 33 8.
53. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986 136 : 1231 5.
54. Murakami H, Amagai M, Higashiyama M, Hashimoto K, Chorzelski TP, Bhogal BS, Jenkins RE, Black MM, Zillikens D, Nishikawa T, Hashimoto T. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen. J Dermatol Sci. 1996 13 : 112 7.
55. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-col-lagenous site on the BP180 ectodomain. J Immunol. 1993 151 : 5742 50.
56. Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol. 1997 109 : 573 9.
57. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest. 1993 92 : 2480 8.
58. Yamamoto K, Inoue N, Masuda R, Fujimori A, Saito T, Imajoh-Ohmi S, Shinkai H, Sakiyama H. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid. J Invest Dermatol. 2002 118 : 485 92.
59. Sitaru C, Schmidt E, Petermann S, Munteanu SL, Bröcker EB, Zillikens D. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol. 2002 118 : 664 71.
60. Schmidt E, Obe K, Bröcker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol. 2000 136 : 174 8.
61. Lever WF. Pemphigus and Pemphigoid. Charles C Thomas, Springfield, IL : 1965.
62. Jordon RE, Beutner EH, Witebsky E, Blumental G, Hale WL, Lever WF. Basement zone antibodies in bullous pemphigoid. JAMA. 1967 200 : 751 6.
63. Gammon WR, Briggaman RA, Inman AO, Queen LL, Wheeler CE. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol. 1984 82 : 139 44.
64. Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL. Diagnostic value of indirect immunofluorescence on sodium chloride- split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol. 1997 133 : 1102 7.
65. Ghohestani R, Kanitakis J, Nicolas JF, Cozzani E, Claudy A. Comparative sensitivity of indirect immuno-fluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol. 1996 135 : 74 9.
66. Giudice GJ, Wilske KC, Anhalt GJ, Fairley JA, Taylor AF, Emery DJ, Hoffman RG, Diaz LA. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes ges-tationis. J Invest Dermatol. 1994 102 : 878 81.
67. Zillikens D, Mascaro JM, Rose PA, Liu Z, Ewing SM, Caux F, Hoffmann RG, Diaz LA, Giudice GJ. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol. 1997 109 : 679 83.
68. Haase C, Budinger L, Borradori L, Yee C, Merk HF, Yancey K, Hertl M. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus- encoded form of bullous pemphigoid antigen 2. J Invest Dermatol. 1998 110 : 282 6.
69. Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K, Nishikawa T. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci. 2002 30 : 224 32.
70. Mariotti F, Grosso F, Terracina M, Ruffelli M, Cordiali-Fei P, Sera F, Zambruno G, Mastrogiacomo A, Di Zenzo G. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoanti- body profile in bullous pemphigoid patients. Br J Dermatol. 2004 151 : 1004 10.
71. Yoshida M, Hamada T, Amagai M, Hashimoto K, Uehara R, Yamaguchi K, Imamura K, Okamoto E, Yasumoto S, Hashimoto T. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci. 2006 41 : 21 30
72. Shimanovich I, Bröcker EB, Zillikens D. pemphigoid gestationis: new insights into the pathogenesis lead to novel diagnostic tools. BJOG. 2002 109 : 970 6.
73. Morrison LH, Anhalt GJ. Herpes gestationis. J Autoimmun. 1991 4 : 37 45.
74. Morrison LH, Labib RS, Zone JJ, Diaz LA, Anhalt GJ. Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest. 1988 81 : 2023 6.
75. Kelly SE, Bhogal BS, Wojnarowska F, Whitehead P, Leigh IM, Black MM. Western blot analysis of the antigen in pemphigoid gestationis. Br J Dermatol. 1990 122 : 445 9.
76. Katz A, Minto JO, Toole JW, Medwidsky W. Immunopathologic study of herpes gestationis in mother and infant. Arch Dermatol. 1977 113 : 1069 72.
77. Chorzelski TP, Jablonska S, Beutner EH, Maciejowska E, Jarzabek-Chorzelska M. Herpes gestations with identical lesions in the newborn. Passive transfer of the disease? Arch Dermatol. 1976 112 : 1129 31.
78. Sitaru C, Powell J, Messer G, Bröcker E-B, Wojnarowska F, Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol. 2004 103 : 757 63.
79. Powell AM, Sakuma-Oyama Y, Oyama N, Albert S, Bhogal B, Kaneko F, Nishikawa T, Black MM. Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy. Arch Dermatol. 2005 141 : 705 10.
80. Bowen JT. Five cases of bullous dermatitis (DH) in children following vaccination. Br J Dermatol. 1901 8 : 392 4.
81. Chorzelski TP, Jablonska S. IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol. 1979 101 : 535 42.
82. Danielsen AG, Thomsen K. Vancomycin-induced linear IgA bullous disease. Br J Dermatol. 1999 141 : 756 7.
83. Palmer RA, Ogg G, Allen J, Banerjee A, Ryatt KS, Ratnavel R, Wojnarowska F. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol. 2001 145 : 816 20.
84. Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cica-tricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988 19 : 792 805.
85. Wojnarowska F, Frith P. Linear IgA disease. Dev Ophthalmol. 1997 28 : 64 72.
86. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol. 2001 19 : 719 27.
87. Chan LS, Regezi JA, Cooper KD. Oral manifesta-tions of linear IgA disease. J Am Acad Dermatol. 1990 22 : 362 5.
88. Kelly SE, Frith PA, Millard PR, Wojnarowska F, Black MM. A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol. 1988 119 : 161 70.
89. Zone JJ, Taylor TB, Kadunce DP, Meyer LJ. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A disease. J Clin Invest. 1990 85 : 812 20.
90. Marinkovich MP, Taylor TB, Keene DR, Burgeson RE, Zone JJ. LAD-1, the linear IgA bullous dermato-sis autoantigen, is a novel 120- kD anchoring filament protein synthesized by epidermal cells. J Invest Dermatol. 1996 106 : 734 8.
91. Pas HH, Kloosterhuis GJ, Heeres K, Van Der Meer JB, Jonkman MF. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kD ker-atinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol. 1997 108 : 423 9.
92. Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K. Cleavage of BP180, a 180-kD bullous pemphigoid antigen, yields a 120- kD collage-nous extracellular polypeptide. J Biol Chem. 1998 273 : 9711 7.
93. Zone JJ, Taylor TB, Meyer LJ, Petersen MJ. The 97 kD linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kD bul-lous pemphigoid antigen, BPAg2. J Invest Dermatol. 1998 110 : 207 10.
94. Hirako Y, Nishizawa Y, Sitaru C, Opitz A, Marcus K, Meyer HE, Butt E, Owaribe K, Zillikens D. The 97-kD (LABD97) and 120-kD (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have differ-ent N-termini. J Invest Dermatol. 2003 121 : 1554 6.
95. Vodegel RM, de Jong MC, Pas HH, Jonkman MF. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol. 2002 47 : 919 25.
96. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost-Squarcioni C, Rogers RS 3 rd., Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002 138 : 370 9
97. Leverkus M, Schmidt E, Lazarova Z, Bröcker EB, Yancey KB, Zillikens D. Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous dis-eases? Arch Dermatol. 1999 135 : 1091 8.
98. Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Bröcker E-B, Yancey KB, Zillikens D. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol. 2001 145 : 778 83.
99. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfer of anti-laminin 5 antibod-ies induces subepidermal blisters in neonatal mice. J Clin Invest. 1996 98 : 1509 18.
100. Lazarova Z, Hsu R, Yee C, Yancey KB. Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model. J Invest Dermatol. 2000 114 : 178 84.
101. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA. 1996 93 : 14714 9.
102. Bhol K, Mohimen A, Neumann R, Yunis J, Foster S, Yunis EJ, Ahmed AR. Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid. Curr Eye Res. 1996 15 : 521 32.
103. Chan RY, Bhol K, Tesavibul N, Letko E, Simmons RK, Foster CS, Ahmed AR. The role of antibody to human beta4 integrin in conjunctival basement membrane sepa-ration: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci. 1999 40 : 2283 90.
104. Colon JE, Bhol KC, Razzaque MS, Ahmed AR. In vitro organ culture model for mucous membrane pemphigoid. Clin Immunol. 2001 98 : 229 34.
105. Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR. Autoantibodies to alpha 6 integrin in patients with oral pemphigoid. J Dent Res. 2001 80 : 1711 5.
106. Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I. Anti-p200 pemphigoid: a novel autoim-mune subepidermal blistering disease. J Dermatol. 2007 34 : 1 8.
107. Shimanovich I, Hirako Y, Sitaru C, Butt E, Hashimoto T, Bröcker EB, Zillikens D. The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glyco-protein of the cutaneous basement membrane. J Invest Dermatol. 2003 121 : 1402 8.
108. Zillikens D, Ishiko A, Jonkman MF, Chimanovitch I, Shimizu H, Hashimoto T, Bröcker EB. Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen. Br J Dermatol. 2000 143 : 1043 9.
109. Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Brocker EB, Hashimoto T. A novel subepidermal blistering disease with autoantibodies to a 200-kD antigen of the basement membrane zone. J Invest Dermatol. 1996 106 : 1333 8.
110. Umemoto N, Demitsu T, Toda S, Noguchi T, Suzuki SI, Kakurai M, Yamada T, Suzuki M, Nakagawa H, Komai A, Hashimoto T. A case of anti-p200 pemphigoid clinically mimicking inflammatory epidermolysis bullosa acquisita. Br J Dermatol. 2003 148 : 1058 60.
111. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin base-ment- membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med. 1984 310 : 1007 13.
112. Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese MJ, Briggaman RA. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest. 1988 81 : 683 7.
113. Sitaru C, Kromminga A, Hashimoto T, Bröcker EB, Zillikens D. Autoantibodies to type VII collagen mediate Fcgamma-dependent granulocyte activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol. 2002 161 : 301 11.
114. Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Brocker EB, Opdenakker G, Zillikens D, Sitaru C. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol. 2004 204 : 519 27.
115. Sitaru C, Mihai S, Otto C, Chiriac MT, Haußer I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D. Induction of dermal-epidermal separation in mice by passive transfer of antibodies to type VII collagen. J Clin Invest. 2005 115 : 870 8.
116. Woodley DT, Chang C, Saadat P, Ram R, Liu Z, Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol. 2005 124 : 958 64.
117. Sitaru C, Chiriac MT, Mihai S, Büning J, Gebert A, Ishiko A, Zillikens D. Induction of complement-fixing autoantibodies against type VII collagen results in subepi-dermal blistering in mice. J Immunol. 2006 177 : 3461 8.
118. Sitaru C. Experimental models of epidermolysis bullosa acquisita. Exp Dermatol. 2007 16 : 520 31.
119. Elliott GT. Two cases of epidermolysis bullosa. J Cutan Genitourin. 1895 13 : 10.
120. Roenigk HH, Jr., Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol. 1971 103 : 1 10.
121. Dahl MG. Epidermolysis bullosa acquisita-a sign of cica-tricial pemphigoid? Br J Dermatol. 1979 101 : 475 84.
122. Gammon WR, Briggaman RA, Wheeler CE, Jr. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol. 1982 7 : 382 7.
123. Gammon WR, Briggaman RA, Woodley DT, Heald PW, Wheeler CE, Jr. Epidermolysis bullosa acquisita-a pemphigoid- like disease. J Am Acad Dermatol. 1984 11 : 820 32.
124. Stewart MI, Woodley DT, Briggaman RA. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Arch Dermatol. 1991 127 : 373 7.
125. Callot-Mellot C, Bodemer C, Caux F, Bourgault-Villada I, Fraitag S, Goudie G, Heller M, de Prost Y, Prost C. Epidermolysis bullosa acquisita in childhood. Arch Dermatol. 1997 133 : 1122 6.
126. Schmidt E, Höpfner B, Chen M, Kuhn C, Weber L, Bruckner-Tuderman L, Bröcker E-B, Zillikens D. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to the three structural domains of type VII collagen. Br J Dermatol. 2002 147 : 592 7.
127. Mayuzumi M, Akiyama M, Nishie W, Ukae S, Abe M, Sawamura D, Hashimoto T, Shimizu H. Childhood epi-dermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. Br J Dermatol. 2006 155 : 1048 52.
128. Zhu XJ, Niimi Y, Bystryn JC. Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol. 1990 126 : 171 4.
129. Woodley DT, Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita. In : Freedberg, IM, Eisen, AZ, Wolff, K, Austen, KF, Goldsmith, LA, Katz, SI and Fitzpatrick, TB, editors. Fitzpatrick's Dermatology in gen-eral medicine, 4 th ed. New York : McGraw-Hill 1999. p. 702 9.
130. Woodley DT, Briggaman RA, Gammon WR. Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. Dermatol Clin. 1990 8 : 717 26.
131. Fine JD, Tyring S, Gammon WR. The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol. 1989 92 : 27 32.
132. Yaoita H, Briggaman RA, Lawley TJ, Provost TT, Katz SI. Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol. 1981 76 : 288 92.
133. Ishii N, Yoshida M, Hisamatsu Y, Ishida-Yamamoto A, Nakane H, Iizuka H, Tanaka T, Hashimoto T. Epidermolysis bullosa acquisita sera react with dis-tinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol. 2004 150 : 843 51.
134. Stanley JR, Rubinstein N, Klaus-Kovtun V. Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol. 1985 85 : 542 5.
135. Chen M, Chan LS, Cai X, O'Toole EA, Sample JC, Woodley DT. Development of an ELISA for rapid detec-tion of anti-type VII collagen autoantibodies in epidermoly-sis bullosa acquisita. J Invest Dermatol. 1997 108 : 68 72.
136. Rose C, Zillikens D. Dermatitis herpetiformis Duhring. In : Hertl, M. editor. Autoimmune diseases of the skin. Wien : Springer 2001. 85 98.
137. Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005 128 : S87 91.
138. Duhring L. Dermatitis herpetiformis. JAMA. 1884 3 : 225 9.
139. Marks J, Shuster S, Watson AJ. Small-bowel changes in dermatitis herpetiformis. Lancet. 1966 2 : 1280 2.
140. Marks R, Whittle MW, Beard RJ, Robertson WB, Gold SC. Small-bowel abnormalities in dermatitis herpeti-formis. Br Med J. 1968 1 : 552 5.
141. Marks R. Dermatitis herpetiformis and the gastro-intestinal tract. Trans St Johns Hosp Dermatol. Soc 1968 54 : 141 7.
142. Sachs JA, Awad J, McCloskey D, Navarrete C, Festenstein H, Elliot E, Walker-Smith JA, Griffiths CE, Leonard JN, Fry L. Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis. Gut. 1986 27 : 515 20.
143. Cormane RH. Immunofluorescent studies of the skin in lupus erythematosus and other diseases. Pathologica Eur. 1967 2 : 170 80.
144. Meer JBvd. Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immuno-fluorescent study. Br J Dermatol. 1969 81 : 493 503.
145. Reunala T. Dermatitis herpetiformis: coeliac disease of the skin. Ann Med. 1998 30 : 416 8.
146. Reunala TL. Dermatitis herpetiformis. Clin Dermatol. 2001 19 : 728 36.
147. Stingl G, Honigsmann H, Holubar K, Wolff K. Ultrastructural localization of immunoglobulins in skin of patients with dermatitis herpetiformis. J Invest Dermatol. 1976 67 : 507 12.
148. Smith JB, Taylor TB, Zone JJ. The site of blister formation in dermatitis herpetiformis is within the lamina lucida. J Am Acad Dermatol. 1992 27 : 209 13.
149. Klein GF, Hintner H, Schuler G, Fritsch P. Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae. Br J Dermatol. 1983 109 : 499 508.
150. Beutner EH, Chorzelski TP, Reunala TL, Kumar V. Immunopathology of dermatitis herpetiformis. Clin Dermatol. 1991 9 : 295 311.
151. Zone JJ, Meyer LJ, Petersen MJ. Deposition of gran-ular IgA relative to clinical lesions in dermatitis her-petiformis. Arch Dermatol. 1996 132 : 912 8.
152. Kadunce DP, Meyer LJ, Zone JJ. IgA class antibod-ies in dermatitis herpetiformis: reaction with tissue antigens. J Invest Dermatol. 1989 93 : 253 8.
153. Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V. IgA class endomysium anti-bodies in dermatitis herpetiformis and coeliac dis-ease. Ann N Y Acad Sci. 1983 420 : 325 34.
154. Reunala T, Chorzelski TP, Viander M, Sulej J, Vainio E, Kumar V, Beutner EH. IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and anti-gliadin antibodies. Br J Dermatol. 1987 117 : 185 91.
155. Dieterich W, Laag E, Bruckner-Tuderman L, Reunala T, Karpati S, Zagoni T, Riecken EO, Schuppan D. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis her-petiformis. J Invest Dermatol. 1999 113 : 133 6.
156. Rose C, Dieterich W, Bröcker EB, Schuppan D, Zillikens D. Circulating autoantibodies to tissue trans-glutaminase differentiate patients with dermatitis her-petiformis from those with linear IgA disease. J Am Acad Dermatol. 1999 41 : 957 61.
157. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002 195 : 747 57.
158. Marietta E, Black K, Camilleri M, Krause P, Rogers RS, 3 rd., David C, Pittelkow MR, Murray JA. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest. 2004 114 : 1090 7.
159. Hendrix JD, Mangum KL, Zone JJ, Gammon WR. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neu-trophils. J Invest Dermatol. 1990 94 : 667 72.
160. Baican A, Hirako Y, Lazarova Z, Yancey KB, Zillikens D, Sitaru C. IgG autoantibodies to type VII collagen and an exclusive IgG3 reactivity to the laminin 3 chain in a patient with an autoimmune subepidermal blistering disease. J Am Acad Dermatol. 2005 53 : 517 22.